PFO
TDOC icon

Pathstone Family Office’s Teladoc Health TDOC Stock Holding History

Pathstone Family Office’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,233
Closed -$454K – 1133
2022
Q1 		$454K Buy
6,233
+83
+1% +$5.98K 0.01% 582
2021
Q4 		$564K Buy
6,150
+373
+6% +$44.6K 0.01% 513
2021
Q3 		$732K Buy
5,777
+283
+5% +$41.2K 0.02% 377
2021
Q2 		$914K Buy
5,494
+136
+3% +$22K 0.03% 292
2021
Q1 		$974K Buy
5,358
+5,258
+5,258% +$1.22M 0.03% 211
2020
Q4 		$20K Hold
100
– – ﹤0.01% 698
2020
Q3 		$22K Hold
100
– – ﹤0.01% 464
2020
Q2 		$19K Sell
100
-100
-50% -$17.5K ﹤0.01% 432
2020
Q1 		$31K Buy
+200
New +$23.3K ﹤0.01% 368
2019
Q2 		– Sell
-32
Closed -$2K – 883
2019
Q1 		$2K Buy
+32
New +$1.95K ﹤0.01% 806

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Pathstone Family Office's TDOC Position: Q2 2022 in Review

Pathstone Family Office sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 6,233 shares — an estimated $454K sold.

Pathstone Family Office first reported a position in TDOC in Q1 2019 and held it in 10 quarters. The position peaked at $974K in Q1 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Pathstone Family Office reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Pathstone Family Office sold 6,233 Teladoc Health shares in Q2 2022, an estimated $454K.
  • Pathstone Family Office first reported a position in Teladoc Health in Q1 2019 and held it in 10 quarters.
  • Pathstone Family Office's Teladoc Health position peaked at $974K in Q1 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Pathstone Family Office's 13F filing for Q2 2022, filed 15 Aug 2022.